Bold claim: Osteoprotegerin (OPG) is more than just a bone guardian — it sits at a crossroads with cardiovascular disease, linking bone biology to heart health in surprising ways. A new article in Cardiovascular Innovations and Applications explores how a glycoprotein from the tumor necrosis factor family helps regulate bone metabolism by curbing osteoclast formation and activation, yet also plays a pivotal role in cardiovascular pathology.
OPG’s importance extends beyond bones. Growing evidence shows that higher circulating OPG levels correlate with atherosclerosis, arterial calcification, and heart failure, suggesting OPG participates in cardiac remodeling and vascular disease. It appears to influence calcification and vascular stability by preventing vascular smooth muscle cells from adopting osteogenic (bone-like) characteristics. Abnormal OPG expression is seen in cardiovascular risk conditions such as aortic valve stenosis, chronic kidney disease, and diabetes.
Beyond structural effects, OPG engages with inflammatory and cell-survival signals through partners like RANKL and TRAIL. These interactions weave together bone biology, inflammation, and vascular dysfunction. In particular, elevated OPG and shifts in the OPG/TRAIL ratio have been linked to myocardial infarction, adverse left ventricular remodeling, and higher mortality risk.
This review synthesizes molecular and clinical perspectives on OPG’s multifaceted role in cardiovascular diseases, emphasizing its potential as both a regulator of disease processes and a predictive biomarker. In cardiovascular medicine, the OPG/RANKL/TRAIL axis holds promise for guiding targeted therapies and refining risk assessment.
Source:
Lutfu Askin, Okan Tanrıverdi, Erdem Kaya, et al. Integrative Mechanisms of Osteoprotegerin in Cardiovascular Pathophysiology. CVIA. 2026. Vol. 11(1). DOI: 10.15212/CVIA.2025.0035. https://www.scienceopen.com/hosted-document?doi=10.15212/CVIA.2025.0035
Suggested Reading
Notes
- This rewritten content preserves the original meaning and key information while presenting it with fresh wording and structure. It expands slightly by clarifying mechanisms and context, and it keeps a professional, engaging tone.
- For readers new to the topic, OPG is introduced as a molecule that bridges bone health and heart health, with concrete examples of how it relates to disease and potential clinical implications.
Would you like this rewritten piece tailored for a specific audience (e.g., clinicians, students, or lay readers) or adjusted for a particular publication style (e.g., more concise abstract vs. feature article)?
